Patient presenting features
Age at diagnosis, y | No. (%) |
Younger than 1 | 15 (3.6) |
1 to 9 | 259 (62.9) |
10 or older | 138 (33.5) |
Sex | |
Male | 236 (57.3) |
Female | 176 (42.7) |
Race | |
White | 311 (75.5) |
Black | 68 (16.5) |
Other | 33 (8.0) |
WBC count, cells/mm3 | |
Lower than 50 000 | 302 (73.3) |
50 000 or higher | 110 (26.7) |
DNA index | |
1.16 or higher | 92 (22.3) |
Other | 320 (77.7) |
CNS status | |
CNS-2, 3 or traumatic with blasts | 166 (40.3) |
CNS-1, traumatic without blasts | 246 (59.7) |
Lineage | |
B | 346 (84.0) |
T | 66 (16.0) |
Philadelphia chromosome | |
Absent | 397 (96.4) |
Present | 13 (3.2) |
Not known | 2 (0.5) |
t(1;19) | |
Absent | 386 (93.7) |
Present | 18 (4.4) |
Not known | 8 (1.9) |
t(4;11) | |
Absent | 393 (95.4) |
Present | 11 (2.7) |
Not known | 8 (1.9) |
TEL/AML1 | |
Absent | 335 (81.3) |
Present | 60 (14.6) |
Not known | 17 (4.1) |
Received G-CSF | |
Yes | 99 (24.0) |
No | 313 (76.0) |
Received irradiation | |
Yes | 57 (13.8) |
No | 355 (86.2) |
Age at diagnosis, y | No. (%) |
Younger than 1 | 15 (3.6) |
1 to 9 | 259 (62.9) |
10 or older | 138 (33.5) |
Sex | |
Male | 236 (57.3) |
Female | 176 (42.7) |
Race | |
White | 311 (75.5) |
Black | 68 (16.5) |
Other | 33 (8.0) |
WBC count, cells/mm3 | |
Lower than 50 000 | 302 (73.3) |
50 000 or higher | 110 (26.7) |
DNA index | |
1.16 or higher | 92 (22.3) |
Other | 320 (77.7) |
CNS status | |
CNS-2, 3 or traumatic with blasts | 166 (40.3) |
CNS-1, traumatic without blasts | 246 (59.7) |
Lineage | |
B | 346 (84.0) |
T | 66 (16.0) |
Philadelphia chromosome | |
Absent | 397 (96.4) |
Present | 13 (3.2) |
Not known | 2 (0.5) |
t(1;19) | |
Absent | 386 (93.7) |
Present | 18 (4.4) |
Not known | 8 (1.9) |
t(4;11) | |
Absent | 393 (95.4) |
Present | 11 (2.7) |
Not known | 8 (1.9) |
TEL/AML1 | |
Absent | 335 (81.3) |
Present | 60 (14.6) |
Not known | 17 (4.1) |
Received G-CSF | |
Yes | 99 (24.0) |
No | 313 (76.0) |
Received irradiation | |
Yes | 57 (13.8) |
No | 355 (86.2) |